About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 579 record(s)
Req # A-2020-000474
As part of the diligent audit of Beauce Caoutchouc Inc. Companies, obtain certain information regarding the status of those companies' files with your organization.Organization: Health Canada
July 2020
Req # A-2020-000540
The number of patient complaints submitted to each provincial College of Physicians and Surgeons in Canada in 2018.Organization: Health Canada
July 2020
Req # A-2020-000581
Documents regarding the Gardasil vaccine in relation to the decision to grant Gardasil Priority Review status, approval, communications between Health Canada (HC) and Merck Frosst Canada Ltd, and communications between HC and United States Food and Drug Administration (Jan 1, 2005 to Dec 31, 2006).Organization: Health Canada
July 2020
Req # A-2020-000634
All records describing the isolation of a SARS-COV-2 virus, directly from a sample taken from a diseased patient, where the patient sample was not first combined with any other source of genetic material (i.e. monkey kidney cells aka vero cells; liver cancer cells).Organization: Health Canada
July 2020
Req # A-2019-000608
Adverse Reaction Report (AER) for Pantoprazole. Report numbers: E2B_02315425, E2B_02325522, E2B_02302367, E2B_02403900, E2B_02277130, E2B_02297379, E2B_02306660, E2B_02306664, E2B_02306665, E2B_02306940, E2B_02307238, E2B_02307245, E2B_02311507, E2B_02311508, E2B_02344228, E2B_02420173, E2B_02421783, 722202.Organization: Health Canada
July 2020
Req # A-2019-001133
Adverse Reaction Report (AER) for Cipralex® (escitalopram), Celexa® (citalopram). Report numbers: 000721686, 000721945, 000722137, E2B_02320967, E2B_02328417, E2B_02339130, E2B_02344885, E2B_02346046, E2B_02350000.Organization: Health Canada
July 2020
Req # A-2019-001136
Adverse Reaction Report (AER). Report number: E2B_02332753.Organization: Health Canada
July 2020
Req # A-2019-001214
Adverse Reaction Report (AER) for leflunomide. Report numbers: E2B_02275848, E2B_02278473, E2B_01838371, E2B_02248128, E2B_02497497 E2B_02278878, E2B_02280058, E2B_02280071, E2B_02424014, E2B_02517901, E2B_02281749, E2B_02283734, E2B_02308934, E2B_02313555, E2B_02285079, E2B_02307572, E2B_02293881, E2B_02290008, E2B_02288334, E2B_02304574, E2B_02309665, E2B_02309773, E2B_02231328, E2B_02231426, E2B_01473947, E2B_02231521, E2B_02232328, E2B_02255762.Organization: Health Canada
July 2020
Req # A-2019-001382
Adverse Reaction Report (AER). Report numbers: E2B_02065153, E2B_02382135, E2B_02390568, E2B_02407795, E2B_02161795, E2B_00311007.Organization: Health Canada
July 2020
Req # A-2019-001554
Adverse Reaction Report (AER) for Pms-carbamazepine. Report number: 000721643, 000722217. AER for Pms-zopiclone. Report number: E2B_02105402. AER for Pms-mirtazapine. Report number: E2B_01617063.Organization: Health Canada
July 2020